Shun‐Hsing Hung

603 total citations
21 papers, 447 citations indexed

About

Shun‐Hsing Hung is a scholar working on Infectious Diseases, Epidemiology and Neurology. According to data from OpenAlex, Shun‐Hsing Hung has authored 21 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in Neurology. Recurrent topics in Shun‐Hsing Hung's work include COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Long-Term Effects of COVID-19 (4 papers). Shun‐Hsing Hung is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Long-Term Effects of COVID-19 (4 papers). Shun‐Hsing Hung collaborates with scholars based in Taiwan and China. Shun‐Hsing Hung's co-authors include Kun‐Hung Shen, Yuan‐Wei Shih, Po‐Lin Kuo, Chih‐Cheng Lai, Ya‐Ling Hsu, Cheng‐Hsun Wu, Changliang Liu, Wei‐Ting Lin, Li‐Te Yin and Shen-Peng Chang and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and Carcinogenesis.

In The Last Decade

Shun‐Hsing Hung

19 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shun‐Hsing Hung Taiwan	9	184	84	83	72	70	21	447
Hamid‐Reza Mohammadi‐Motlagh Iran	13	189 1.0×	169 2.0×	58 0.7×	74 1.0×	29 0.4×	26	535
Yanyan Cen China	17	241 1.3×	57 0.7×	56 0.7×	59 0.8×	51 0.7×	23	632
Danfeng Li China	17	286 1.6×	53 0.6×	73 0.9×	44 0.6×	44 0.6×	41	643
Aporn Chuncharunee Thailand	16	217 1.2×	44 0.5×	62 0.7×	53 0.7×	43 0.6×	27	565
Ling Chai China	12	395 2.1×	99 1.2×	28 0.3×	92 1.3×	44 0.6×	24	715
Vi Nguyen United States	11	98 0.5×	37 0.4×	77 0.9×	36 0.5×	31 0.4×	19	479
Jiabin Li China	14	204 1.1×	31 0.4×	89 1.1×	69 1.0×	97 1.4×	53	577
Guijun Zhang China	12	145 0.8×	17 0.2×	83 1.0×	51 0.7×	74 1.1×	38	554
Dan Cao China	14	373 2.0×	42 0.5×	94 1.1×	28 0.4×	20 0.3×	26	595
Sheng‐Wen Wu Taiwan	14	224 1.2×	39 0.5×	24 0.3×	72 1.0×	33 0.5×	42	550

Countries citing papers authored by Shun‐Hsing Hung

Since Specialization

Citations

This map shows the geographic impact of Shun‐Hsing Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shun‐Hsing Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shun‐Hsing Hung more than expected).

Fields of papers citing papers by Shun‐Hsing Hung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shun‐Hsing Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shun‐Hsing Hung. The network helps show where Shun‐Hsing Hung may publish in the future.

Co-authorship network of co-authors of Shun‐Hsing Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Shun‐Hsing Hung. A scholar is included among the top collaborators of Shun‐Hsing Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shun‐Hsing Hung. Shun‐Hsing Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hung, Shun‐Hsing, et al.. (2022). The impact of COVID-19 on the epidemiology of non-airborne/droplet-transmitted notifiable infectious diseases in Taiwan: A descriptive study. Journal of Infection and Public Health. 15(9). 1001–1005. 3 indexed citations

Hsu, Chi‐Kuei, et al.. (2022). Effect of sofosbuvir-based treatment on clinical outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials. International Journal of Antimicrobial Agents. 59(3). 106545–106545. 12 indexed citations

Lan, Shao‐Huan, Chi‐Kuei Hsu, Chih‐Cheng Lai, et al.. (2022). Effect of colchicine on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials. Annals of Medicine. 54(1). 1956–1965. 5 indexed citations

Lan, Shao‐Huan, Chih‐Cheng Lai, Shen-Peng Chang, et al.. (2022). Favipiravir-based treatment for outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Expert Review of Clinical Pharmacology. 15(6). 759–766. 7 indexed citations

Lan, Shao‐Huan, Chih‐Cheng Lai, Shen-Peng Chang, et al.. (2022). Accelerated-strategy renal replacement therapy for critically ill patients: A systematic review and meta-analysis. Medicine. 101(27). e29747–e29747. 1 indexed citations

Lin, Wei‐Ting, Shun‐Hsing Hung, Chih‐Cheng Lai, Cheng‐Yi Wang, & Chao‐Hsien Chen. (2022). The impact of neutralizing monoclonal antibodies on the outcomes of COVID‐19 outpatients: A systematic review and meta‐analysis of randomized controlled trials. Journal of Medical Virology. 94(5). 2222–2229. 39 indexed citations

Lan, Shao‐Huan, Shun‐Hsing Hung, Shen-Peng Chang, et al.. (2022). Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials. Expert Review of Anti-infective Therapy. 20(9). 1205–1215. 5 indexed citations

Lai, Chih‐Cheng, Shao‐Huan Lan, Shen-Peng Chang, et al.. (2021). Novel β-lactam/β-lactamase inhibitor combinations versus alternative antibiotics in adults with hospital-acquired pneumonia or ventilator-associated pneumonia: an integrated analysis of three randomised controlled trials. Journal of Global Antimicrobial Resistance. 29. 398–404.

Hsu, Chi‐Kuei, et al.. (2021). Clinical efficacy and safety of interferon-β–containing regimens in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Expert Review of Anti-infective Therapy. 20(5). 741–747. 7 indexed citations

10.

Lan, Shao‐Huan, Hong‐Zin Lee, Chih‐Cheng Lai, et al.. (2021). Clinical efficacy and safety of ceftobiprole in the treatment of acute bacterial skin and skin structure infection: a systematic review and meta-analysis of randomized controlled trials. Expert Review of Anti-infective Therapy. 20(1). 95–102. 8 indexed citations

11.

Lan, Shao‐Huan, Chih‐Cheng Lai, Shen-Peng Chang, et al.. (2020). Vitamin D supplementation and the outcomes of critically ill adult patients: a systematic review and meta-analysis of randomized controlled trials. Scientific Reports. 10(1). 14261–14261. 21 indexed citations

12.

Lan, Shao‐Huan, Chih‐Cheng Lai, Shen-Peng Chang, et al.. (2020). Five-day antibiotic treatment for community-acquired bacterial pneumonia: A systematic review and meta-analysis of randomized controlled trials. Journal of Global Antimicrobial Resistance. 23. 94–99. 11 indexed citations

13.

Lu, Li‐Chin, Chih‐Cheng Lai, Shen-Peng Chang, et al.. (2020). Novel β-Lactam/β-Lactamase inhibitor combinations vs alternative antibiotics in the treatment of complicated urinary tract infections. Medicine. 99(19). e19960–e19960. 3 indexed citations

14.

Wu, Chia‐Lun, Jar‐Yi Ho, Shun‐Hsing Hung, & Dah‐Shyong Yü. (2018). miR‐429 expression in bladder cancer and its correlation with tumor behavior and clinical outcome. The Kaohsiung Journal of Medical Sciences. 34(6). 335–340. 19 indexed citations

15.

Shen, Kun‐Hung, Chun‐Hao Chen, Chien‐Liang Liu, et al.. (2018). Role of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: Experience at a single center. Urological Science. 29(2). 95–95. 4 indexed citations

16.

Yü, Dah‐Shyong, et al.. (2016). Comparison of therapeutic efficacy of lipo-doxorubicin and doxorubicin in treating bladder cancer. Urological Science. 28(4). 200–205. 8 indexed citations

17.

Kuo, Po‐Lin, Kun‐Hung Shen, Shun‐Hsing Hung, & Ya‐Ling Hsu. (2012). CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation. Carcinogenesis. 33(12). 2477–2487. 89 indexed citations

18.

Shen, Kun‐Hung, et al.. (2009). Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway. Molecular and Cellular Biochemistry. 333(1-2). 279–291. 99 indexed citations

19.

Hung, Shun‐Hsing, Kun‐Hung Shen, Cheng‐Hsun Wu, Changliang Liu, & Yuan‐Wei Shih. (2009). α-Mangostin Suppresses PC-3 Human Prostate Carcinoma Cell Metastasis by Inhibiting Matrix Metalloproteinase-2/9 and Urokinase-Plasminogen Expression through the JNK Signaling Pathway. Journal of Agricultural and Food Chemistry. 57(4). 1291–1298. 98 indexed citations

20.

Lin, Min, Young‐Soo Chung, Shun‐Hsing Hung, Ming‐Chu Cheng, & Heungsup Sung. (1990). Comparison of the immunity conferred by different vaccination programs and routes of commercial Newcastle disease vaccines against challenge with recent isolates of velogenic viscerotropic Newcastle disease virus from Taiwan.. 16(1). 33–45. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact